(thirdQuint)Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis.

 30 Patients(2-19 y) are randomly divided into two groups.

 In group 1 leflunomide will be added to conventional treatment, 5-20 mg daily based on weight.

 In group 2 placebo will be prescribed as same as leflunomide.

 The course of treatment is 3 months.

 Every 4 weeks ACRped 30, 50, 70 should be determined to evaluate therapeutic response.

 Side effects of treatment will be assessed by physical examination and lab tests every 4 weeks.

.

 Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis@highlight

A randomized double blind clinical trial to assess efficacy of leflunomide in treatment of refractory juvenile idiopathic arthritis.

 Patients are randomly divided into two groups.

 In group 1 leflunomide and in group 2 placebos will be added to conventional treatment for three months.

 therapeutic responses will be evaluated by ACRpedi (American College of Rheumatology Pediatric) scores every 4 weeks.

